The influence of acute kidney disease on the clinical outcomes of patients who received cisplatin, carboplatin, and oxaliplatin

BACKGROUND AND AIMS: Cisplatin (CDDP) is used as the first line of treatment for some tumors, but its use may be restricted due to its nephrotoxicity. Carboplatin (CARBO) and oxaliplatin (OXA) are less nephrotoxic alternatives to CDDP. This study has the objective to determine the incidence of acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Alexandre Ricardo Da Silva, de Brito, Germana Alves, Baptista, Aline Lourenço, Andrade, Luis André Silvestre, Imanishe, Marina Harume, Pereira, Benedito Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753493/
https://www.ncbi.nlm.nih.gov/pubmed/35036578
http://dx.doi.org/10.1002/hsr2.479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753493/
https://www.ncbi.nlm.nih.gov/pubmed/35036578
http://dx.doi.org/10.1002/hsr2.479

Ejemplares similares